Search research articles
Contact Us
Filters
Showing results (51-60 of 154) with videos related to
Page
of 16
Sort By:
The Journal of Rheumatology
|
January 6, 2004
Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C
Owonayo Oniankitan, Christophe Duvoux, Dominique Challine, et al.
The Journal of Rheumatology
|
January 6, 2006
Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies
Jean-David Cohen, Patrick Cunin, Valérie Farrenq, et al.
International Journal of Rheumatic Diseases
|
April 17, 2019
Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort
Pascal Claudepierre, Filip Van den Bosch, Piercarlo Sarzi-Puttini, et al.
Arthritis Research & Therapy
|
January 17, 2019
Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data
Adeline Ruyssen-Witrand, Cécile Luxembourger, Alain Cantagrel, et al.
The Journal of Rheumatology
|
April 17, 2008
Cutaneous granulomas during infliximab therapy for spondyloarthropathy
Andra Economu Dubosc, Anne-Marie Perroud, Martine Bagot, et al.
Expert Opinion on Biological Therapy
|
May 27, 2026
Shared challenges in the management of difficult-to-treat chronic inflammatory diseases: expert perspectives
Laure Gossec, Hubert Marotte, Ziad Reguiai, et al.
Joint Bone Spine
|
June 18, 2011
Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI
Cécile Gaujoux-Viala, Gaël Mouterde, Athan Baillet, et al.
Arthritis Care & Research
|
September 16, 2020
Inflammation of the Sacroiliac Joints and Spine and Structural Changes on Magnetic Resonance Imaging in Axial Spondyloarthritis: Five-Year Data From the DESIR Cohort
Alexandre Sepriano, Sofia Ramiro, Robert Landewé, et al.
Journal of Medical Economics
|
April 12, 2016
Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France
Francis Fagnani, Thao Pham, Pascal Claudepierre, et al.
Journal of the American Academy of Dermatology
|
November 17, 2025
Risk of immunogenicity during infliximab therapy in hidradenitis suppurativa compared with other chronic inflammatory diseases: A retrospective monocentric cohort
Camille Barral, Ramatoulaye Ndiaye, Christina Bergqvist, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 154) with videos related to
Sort By:
Page
of 16
The Journal of Rheumatology
|
January 6, 2004
Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C
Owonayo Oniankitan, Christophe Duvoux, Dominique Challine, et al.
The Journal of Rheumatology
|
January 6, 2006
Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies
Jean-David Cohen, Patrick Cunin, Valérie Farrenq, et al.
International Journal of Rheumatic Diseases
|
April 17, 2019
Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort
Pascal Claudepierre, Filip Van den Bosch, Piercarlo Sarzi-Puttini, et al.
Arthritis Research & Therapy
|
January 17, 2019
Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data
Adeline Ruyssen-Witrand, Cécile Luxembourger, Alain Cantagrel, et al.
The Journal of Rheumatology
|
April 17, 2008
Cutaneous granulomas during infliximab therapy for spondyloarthropathy
Andra Economu Dubosc, Anne-Marie Perroud, Martine Bagot, et al.
Expert Opinion on Biological Therapy
|
May 27, 2026
Shared challenges in the management of difficult-to-treat chronic inflammatory diseases: expert perspectives
Laure Gossec, Hubert Marotte, Ziad Reguiai, et al.
Joint Bone Spine
|
June 18, 2011
Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI
Cécile Gaujoux-Viala, Gaël Mouterde, Athan Baillet, et al.
Arthritis Care & Research
|
September 16, 2020
Inflammation of the Sacroiliac Joints and Spine and Structural Changes on Magnetic Resonance Imaging in Axial Spondyloarthritis: Five-Year Data From the DESIR Cohort
Alexandre Sepriano, Sofia Ramiro, Robert Landewé, et al.
Journal of Medical Economics
|
April 12, 2016
Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France
Francis Fagnani, Thao Pham, Pascal Claudepierre, et al.
Journal of the American Academy of Dermatology
|
November 17, 2025
Risk of immunogenicity during infliximab therapy in hidradenitis suppurativa compared with other chronic inflammatory diseases: A retrospective monocentric cohort
Camille Barral, Ramatoulaye Ndiaye, Christina Bergqvist, et al.
Page
of 16